Evercore ISI Group analyst Chris McNally downgrades Lear (NYSE:LEA) from Outperform to In-Line and lowers the price target from $150 to $145.
Evercore ISI Group Downgrades Lear to In-Line, Lowers Price Target to $145
Evercore ISI Group analyst Chris McNally downgrades Lear (NYSE:LEA) from Outperform to In-Line and lowers the price target from $150 to $145.
Related Posts
Morgan Stanley Maintains Underweight on Cheesecake Factory, Lowers Price Target to $26
July 18, 9:56 AM
Morgan Stanley analyst John Glass maintains Cheesecake Factory (NASDAQ:CAKE) with a Underweight and lowers the price target from $37 to $26.
Mizuho Initiates Coverage On Athira Pharma with Buy Rating, Announces Price Target of $6
July 7, 5:16 AM
Mizuho analyst Graig Suvannavejh initiates coverage on Athira Pharma (NASDAQ:ATHA) with a Buy rating and announces Price Target of $6.
The Latest Analyst Ratings for Corvus Pharma
June 16, 3:00 PM
Over the past 3 months, 4 analysts have published their opinion on Corvus Pharma (NASDAQ:CRVS) stock. These analysts…